Long-term quality of life after definitive treatment of sinonasal and nasopharyngeal malignancies.
Nasopharyngeal cancer
quality of life
sinonasal cancer
Journal
The Laryngoscope
ISSN: 1531-4995
Titre abrégé: Laryngoscope
Pays: United States
ID NLM: 8607378
Informations de publication
Date de publication:
01 2020
01 2020
Historique:
received:
10
04
2018
revised:
17
12
2018
accepted:
08
01
2019
pubmed:
2
2
2019
medline:
1
7
2020
entrez:
2
2
2019
Statut:
ppublish
Résumé
To evaluate long-term global and site-specific health-related quality of life (HRQoL) in patients treated for sinonasal and nasopharyngeal malignancies. Cross-sectional. One hundred fourteen patients with sinonasal and nasopharyngeal malignancies received surgery, radiation, systemic chemotherapy, or a combination thereof, with curative intent. Validated global ([EuroQol-5D] Visual Analogue Scale [EQ-5D VAS]) and disease-specific instruments (MD Anderson Symptom Inventory-Head and Neck [MDASI-HN], Anterior Skull Base Questionnaire [ASBQ]) were administered to patients who were both free of disease and had completed treatment at least 12 months previously. Associations between instruments, instrument domains, and specific clinical parameters were analyzed. The median age was 55 years. The mean EQ-5D VAS, MDASI-22 composite score, and ASBQ score were 74 (standard deviation [SD] 21), 48 (SD 36), and 130 (SD 27), respectively. The most frequently reported high-severity items in MDASI-HN were dry mouth and difficulty tasting food. The most frequently reported high-severity items in ASBQ were difficulty with smell and nasal secretions. Advanced Tumor (T) classification was associated with worse overall ASBQ sum score (P = 0.02). ASBQ performance at home and MDASI-HN drowsy symptom items independently predicted worse global HRQoL as measured by the EQ-5D VAS (P < 0.001). Global HRQoL for survivors of sinonasal and nasopharyngeal malignancies after multimodality treatment approximates that of the U.S. population for the same age group. ASBQ and MDASI-HN correlate well with global HRQoL outcomes as measured by EQ-5D VAS. MDASI-HN and ASBQ elicited unique symptoms, highlighting the complex symptom burden experienced by these patients. Further studies should identify patients predisposed to reduced long-term QOL. 3 Laryngoscope, 130:86-93, 2020.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
86-93Informations de copyright
© 2019 The American Laryngological, Rhinological and Otological Society, Inc.
Références
Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann Intern Med 1993;118:622-629.
Patrick DL, Deyo RA. Generic and disease-specific measures in assessing health status and quality of life. Med Care 1989;27:S217-S232.
EuroQol Group. EuroQol-a new facility for the measurement of health-related quality of life. Health Policy 1990;16:199-208.
Bossi P, Saba NF, Vermorken JB, et al. The role of systemic therapy in the management of sinonasal cancer: a critical review. Cancer Treat Rev 2015;41:836-843.
Llorente JL, Lopez F, Suarez C, Hermsen MA. Sinonasal carcinoma: clinical, pathological, genetic and therapeutic advances. Nat Rev Clin Oncol 2014;11:460-472.
Lund VJ, Stammberger H, Nicolai P, et al. European position paper on endoscopic management of tumours of the nose, paranasal sinuses and skull base. Rhinol Suppl 2010;22:1-143.
Hanna EY, Mendoza TR, Rosenthal DI, et al. The symptom burden of treatment-naive patients with head and neck cancer. Cancer 2015;121:766-773.
de Almeida JR, Witterick IJ, Gullane PJ, et al. Quality of life instruments for skull base pathology: systematic review and methodologic appraisal. Head Neck 2013;35:1221-1231.
Kirkman MA, Borg A, Al-Mousa A, Haliasos N, Choi D. Quality-of-life after anterior skull base surgery: a systematic review. J Neurol Surg B Skull Base 2014;75:73-89.
Gunn GB, Mendoza TR, Fuller CD, et al. High symptom burden prior to radiation therapy for head and neck cancer: a patient-reported outcomes study. Head Neck 2013;35:1490-1498.
Rosenthal DI, Mendoza TR, Chambers MS, et al. The M. D. Anderson symptom inventory-head and neck module, a patient-reported outcome instrument, accurately predicts the severity of radiation-induced mucositis. Int J Radiat Oncol Biol Phys 2008;72:1355-1361.
Shi Q, Mendoza TR, Gunn GB, Wang XS, Rosenthal DI, Cleeland CS. Using group-based trajectory modeling to examine heterogeneity of symptom burden in patients with head and neck cancer undergoing aggressive non-surgical therapy. Qual Life Res 2013;22:2331-2339.
Gil Z, Abergel A, Spektor S, et al. Quality of life following surgery for anterior skull base tumors. Arch Otolaryngol Head Neck Surg 2003;129:1303-1309.
Gil Z, Abergel A, Spektor S, Khafif A, Fliss DM. Patient, caregiver, and surgeon perceptions of quality of life following anterior skull base surgery. Arch Otolaryngol Head Neck Surg 2004;130:1276-1281.
Gil Z, Abergel A, Spektor S, Shabtai E, Khafif A, Fliss DM. Development of a cancer-specific anterior skull base quality-of-life questionnaire. J Neurosurg 2004;100:813-819.
Janssen B, Szende A. Population norms for the EQ-5D. In: Szende A, Janssen B, Cabases J, eds. Self-Reported Population Health: An International Perspective Based on EQ-5D. Dordrecht, The Netherlands: Springer; 2014: 19-30.
Deckard NA, Harrow BR, Barnett SL, Batra PS. Comparative analysis of quality-of-life metrics after endoscopic surgery for sinonasal neoplasms. Am J Rhinol Allergy 2015;29:151-155.
Castelnuovo P, Lepera D, Turri-Zanoni M, et al. Quality of life following endoscopic endonasal resection of anterior skull base cancers. J Neurosurg 2013;119:1401-1409.
Bedrosian JC, McCoul ED, Raithatha R, Akselrod OA, Anand VK, Schwartz TH. A prospective study of postoperative symptoms in sinonasal quality-of-life following endoscopic skull-base surgery: dissociations based on specific symptoms. Int Forum Allergy Rhinol 2013;3:664-669.
Derousseau T, Manjunath L, Harrow B, Zhang S, Batra PS. Long-term changes in quality of life after endoscopic resection of sinonasal and skull-base tumors. Int Forum Allergy Rhinol 2015;5:1129-1135.
Glicksman JT, Parasher AK, Brooks SG, et al. Sinonasal quality of life after endoscopic resection of malignant sinonasal and skull base tumors. Laryngoscope 2018;128:789-793.
McCoul ED, Anand VK, Bedrosian JC, Schwartz TH. Endoscopic skull base surgery and its impact on sinonasal-related quality of life. Int Forum Allergy Rhinol 2012;2:174-181.
McCoul ED, Anand VK, Schwartz TH. Improvements in site-specific quality of life 6 months after endoscopic anterior skull base surgery: a prospective study. J Neurosurg 2012;117:498-506.
McCoul ED, Bedrosian JC, Akselrod O, Anand VK, Schwartz TH. Preservation of multidimensional quality of life after endoscopic pituitary adenoma resection. J Neurosurg 2015;123:813-820.
Cheng TM, Cascino TL, Onofrio BM. Comprehensive study of diagnosis and treatment of trigeminal neuralgia secondary to tumors. Neurology 1993;43:2298-2302.
Phan J, Pollard C, 3rd, Brown PD, et al. Stereotactic radiosurgery for trigeminal pain secondary to recurrent malignant skull base tumors. J Neurosurg 2018:1-10.
Tang C, Fischbein NJ, Murphy JD, et al. Stereotactic radiosurgery for retreatment of gross perineural invasion in recurrent cutaneous squamous cell carcinoma of the head and neck. Am J Clin Oncol 2013;36:293-298.